Interestingly, there is crosstalk between the immune response and ferritin formation, a property that has been applied in tumour therapy, for example, using CD8+ activation to induce ferritin formation in tumour cells (Tang et al., 2020). The gene discussed is CD8A; the disease is neoplasm.